Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma

W. J. Babidge, L. M. Butler, M. A. Burton, P. A. Cowled

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Aberrant bcl-2 expression frequently occurs in colorectal carcinoma. The current study investigated if CpG sites in bcl-2 were methylated in colorectal carcinoma and if methylation correlated with loss of expression of bcl-2 mRNA. Methods: Methylation was assessed in 23 matched normal mucosae and colonic carcinomas by Southern blotting with methylation-sensitive enzymes. Expression of bcl-2 mRNA was assessed by Northern blotting. Results: A SacII site in exon 2 of the bcl-2 gene was methylated in 5 carcinomas, plus an adjacent HpaII sites in 1 tumour. SacII site in the bcl-2 promoter were not methylated. Elevated levels of bcl-2 mRNA were detected in 3 carcinomas, 5 showed decreased expression and 4 were unchanged. Conclusions: De novo methylation of CpG sites in exon 2 of the bcl-2 gene occurs during the development of colorectal carcinoma. However, there was no relationship between expression of bcl-2 mRNA and methylation of specific CpG sites.

LanguageEnglish
Pages2809-2814
Number of pages6
JournalAnticancer Research
Volume21
Issue number4 A
Publication statusPublished - 24 Nov 2001

Keywords

  • Apoptosis
  • Bcl-2
  • Colorectal carcinoma
  • Gene expression
  • Methylation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Babidge, W. J., Butler, L. M., Burton, M. A., & Cowled, P. A. (2001). Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. Anticancer Research, 21(4 A), 2809-2814.
Babidge, W. J. ; Butler, L. M. ; Burton, M. A. ; Cowled, P. A. / Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. In: Anticancer Research. 2001 ; Vol. 21, No. 4 A. pp. 2809-2814.
@article{cd67893aa97e4198a3b3021ace8b6f1e,
title = "Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma",
abstract = "Background: Aberrant bcl-2 expression frequently occurs in colorectal carcinoma. The current study investigated if CpG sites in bcl-2 were methylated in colorectal carcinoma and if methylation correlated with loss of expression of bcl-2 mRNA. Methods: Methylation was assessed in 23 matched normal mucosae and colonic carcinomas by Southern blotting with methylation-sensitive enzymes. Expression of bcl-2 mRNA was assessed by Northern blotting. Results: A SacII site in exon 2 of the bcl-2 gene was methylated in 5 carcinomas, plus an adjacent HpaII sites in 1 tumour. SacII site in the bcl-2 promoter were not methylated. Elevated levels of bcl-2 mRNA were detected in 3 carcinomas, 5 showed decreased expression and 4 were unchanged. Conclusions: De novo methylation of CpG sites in exon 2 of the bcl-2 gene occurs during the development of colorectal carcinoma. However, there was no relationship between expression of bcl-2 mRNA and methylation of specific CpG sites.",
keywords = "Apoptosis, Bcl-2, Colorectal carcinoma, Gene expression, Methylation",
author = "Babidge, {W. J.} and Butler, {L. M.} and Burton, {M. A.} and Cowled, {P. A.}",
year = "2001",
month = "11",
day = "24",
language = "English",
volume = "21",
pages = "2809--2814",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 A",

}

Babidge, WJ, Butler, LM, Burton, MA & Cowled, PA 2001, 'Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma', Anticancer Research, vol. 21, no. 4 A, pp. 2809-2814.

Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. / Babidge, W. J.; Butler, L. M.; Burton, M. A.; Cowled, P. A.

In: Anticancer Research, Vol. 21, No. 4 A, 24.11.2001, p. 2809-2814.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma

AU - Babidge, W. J.

AU - Butler, L. M.

AU - Burton, M. A.

AU - Cowled, P. A.

PY - 2001/11/24

Y1 - 2001/11/24

N2 - Background: Aberrant bcl-2 expression frequently occurs in colorectal carcinoma. The current study investigated if CpG sites in bcl-2 were methylated in colorectal carcinoma and if methylation correlated with loss of expression of bcl-2 mRNA. Methods: Methylation was assessed in 23 matched normal mucosae and colonic carcinomas by Southern blotting with methylation-sensitive enzymes. Expression of bcl-2 mRNA was assessed by Northern blotting. Results: A SacII site in exon 2 of the bcl-2 gene was methylated in 5 carcinomas, plus an adjacent HpaII sites in 1 tumour. SacII site in the bcl-2 promoter were not methylated. Elevated levels of bcl-2 mRNA were detected in 3 carcinomas, 5 showed decreased expression and 4 were unchanged. Conclusions: De novo methylation of CpG sites in exon 2 of the bcl-2 gene occurs during the development of colorectal carcinoma. However, there was no relationship between expression of bcl-2 mRNA and methylation of specific CpG sites.

AB - Background: Aberrant bcl-2 expression frequently occurs in colorectal carcinoma. The current study investigated if CpG sites in bcl-2 were methylated in colorectal carcinoma and if methylation correlated with loss of expression of bcl-2 mRNA. Methods: Methylation was assessed in 23 matched normal mucosae and colonic carcinomas by Southern blotting with methylation-sensitive enzymes. Expression of bcl-2 mRNA was assessed by Northern blotting. Results: A SacII site in exon 2 of the bcl-2 gene was methylated in 5 carcinomas, plus an adjacent HpaII sites in 1 tumour. SacII site in the bcl-2 promoter were not methylated. Elevated levels of bcl-2 mRNA were detected in 3 carcinomas, 5 showed decreased expression and 4 were unchanged. Conclusions: De novo methylation of CpG sites in exon 2 of the bcl-2 gene occurs during the development of colorectal carcinoma. However, there was no relationship between expression of bcl-2 mRNA and methylation of specific CpG sites.

KW - Apoptosis

KW - Bcl-2

KW - Colorectal carcinoma

KW - Gene expression

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=0035149596&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 2809

EP - 2814

JO - Anticancer Research

T2 - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 A

ER -